Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/33998
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Protein-protein interaction antagonists as novel inhibitors of non-canonical polyubiquitylation |
Autor: | Scheper, Johanna CSIC; Guerra-Rebollo, Marta CSIC ORCID; Sanclimens, Glòria CSIC; Moure, Alejandra CSIC; Masip, Isabel CSIC; González Ruiz, Domingo; Rubio, Nuria CSIC; Crosas, Bernat CSIC ORCID ; Meca-Cortés, Óscar CSIC ORCID; Loukili, Noureddine; Plans, Vanessa; Morreale, Antonio; Blanco, Jerónimo CSIC ORCID; Ortiz, Ángel R. CSIC; Messeguer Peypoch, Ángel CSIC ORCID; Thomson, Timothy M. CSIC ORCID | Palabras clave: | Polyubiquitylation Lysine |
Fecha de publicación: | 30-jun-2010 | Editor: | Public Library of Science | Citación: | PLoS ONE 5(6): e11403 (2010) | Resumen: | [Background]: Several pathways that control cell survival under stress, namely RNF8-dependent DNA damage recognition and repair, PCNA-dependent DNA damage tolerance and activation of NF-kB by extrinsic signals, are regulated by the tagging of key proteins with lysine 63-based polyubiquitylated chains, catalyzed by the conserved ubiquitin conjugating heterodimeric enzyme Ubc13-Uev. [Methodology/Principal Findings]: By applying a selection based on in vivo protein-protein interaction assays of compounds from a combinatorial chemical library followed by virtual screening, we have developed small molecules that efficiently antagonize the Ubc13-Uev1 protein-protein interaction, inhibiting the enzymatic activity of the heterodimer. In mammalian cells, they inhibit lysine 63-type polyubiquitylation of PCNA, inhibit activation of NF-kB by TNF-a and sensitize tumor cells to chemotherapeutic agents. One of these compounds significantly inhibited invasiveness, clonogenicity and tumor growth of prostate cancer cells. [Conclusions/Significance]: This is the first development of pharmacological inhibitors of non-canonical polyubiquitylation that show that these compounds produce selective biological effects with potential therapeutic applications. | Versión del editor: | http://dx.doi.org/10.1371/journal.pone.0011403 | URI: | http://hdl.handle.net/10261/33998 | DOI: | 10.1371/journal.pone.0011403 | ISSN: | 1932-6203 |
Aparece en las colecciones: | (CBM) Artículos (CIC) Artículos (IQAC) Artículos (IBMB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Protein-protein.pdf | 745,3 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
17
checked on 23-ene-2024
SCOPUSTM
Citations
32
checked on 14-mar-2024
WEB OF SCIENCETM
Citations
29
checked on 23-feb-2024
Page view(s)
406
checked on 18-mar-2024
Download(s)
198
checked on 18-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.